Combining Observational and Physiologic Sedation Assessment Tools
NCT ID: NCT00538369
Last Updated: 2015-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
67 participants
INTERVENTIONAL
2006-11-30
2007-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Composite Variability Index Versus Bispectral Index (BIS)
NCT01053611
EEG-based Depth of Anesthesia-monitoring, Effects on Dosage and Cognition
NCT04529304
Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol
NCT05533567
Memory & Conditioning Under Anesthesia
NCT04062123
Evaluation of NoL Index and ANI After Nociceptive Stimulation at Different Infusion Rates of Remifentanil Infusion
NCT02602379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Questions
* Is there less sedation drug use for patients when nurses monitor sedation with BIS augmentation of Ramsay than when nurses monitor patients with Ramsay alone?
* Is sedation assessment augmented by BIS use associated with a decreased time to wake-up (recovery time) when nurses are instructed to interrupt sedation and obtain a neurologic examination, compared to use of Ramsay alone?
* Are there differences in the number of events associated with undersedation (e.g., self-extubation) for patients assigned to BIS augmentation compared to patients assigned to Ramsay alone?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard-of-care
The standard-of-care group will receive sedation assessment and monitoring with the Ramsay scale, which is the accepted tool at this university
Ramsay Scale
While receiving sedation, subjects will be monitored with the Ramsay scale
standard + BIS
Subjects in the standard-of-care + BIS group will receive sedation assessment and monitoring using the Ramsay scale and values from the bispectral index (BIS) monitor.
Ramsay Scale
While receiving sedation, subjects will be monitored with the Ramsay scale
Bispectral index monitor
While receiving sedation, subjects will receive BIS monitoring
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ramsay Scale
While receiving sedation, subjects will be monitored with the Ramsay scale
Bispectral index monitor
While receiving sedation, subjects will receive BIS monitoring
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted with a neurological or neurosurgical diagnosis
* intubated and on mechanical ventilatory support
* receiving continuous sedation with propofol
* Glasgow Coma Score \<12
Exclusion Criteria
* status epilepticus
* barbiturate coma therapy
* continuous benzodiazepine administration
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina
OTHER
Medtronic - MITG
INDUSTRY
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
DaiWai M Olson, PhD RN CCRN
Role: PRINCIPAL_INVESTIGATOR
Duke University
Suzanne M Thoyre, PhD RN
Role: STUDY_CHAIR
University of North Carolina, Chapel Hill
Carmelo Graffagnino, MD FRCPC
Role: STUDY_DIRECTOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke University Medical Center
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974 Jun 22;2(5920):656-9. doi: 10.1136/bmj.2.5920.656.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8771-06 - 8RO
Identifier Type: -
Identifier Source: secondary_id
Pro00008519
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.